倍通数智赴港IPO：上半年营收增4.9%至1.3亿，首创渠道数据直连解决方案

Core Viewpoint - Beitong Smart Cayman Holdings Limited has submitted its prospectus to the Hong Kong Stock Exchange, with CCB International as the sole sponsor, positioning itself as a data empowerment provider in China's healthcare industry [2] Group 1: Company Overview - Beitong Smart focuses on building a comprehensive intelligent data platform for the healthcare industry, leveraging vast data assets and industry expertise to cover the entire product lifecycle and integrate pharmaceutical distribution channels seamlessly [2] - The company pioneered the Direct Data Integration (DDI) solution in China's pharmaceutical and medical device sector in 2009 and is ranked second among third-party digital service providers in this field by revenue in 2024, according to Frost & Sullivan [2] Group 2: Financial Performance - The company's revenue for the years 2022 to 2024 is projected to be 221 million RMB, 240 million RMB, and 243 million RMB respectively, with net profit and total comprehensive income of 45.22 million RMB, 33.77 million RMB, and 49.30 million RMB for the same years [4] - In the first half of 2025, Beitong Smart achieved a revenue of 126 million RMB, representing a year-on-year growth of 4.88%, with net profit and total comprehensive income of 30.59 million RMB, reflecting a significant increase of 47.06% year-on-year [2][4]